Pain therapy with oxycodone/naloxone prolonged-release combination: case report
Pain afflicts patients suffering from many chronic diseases and is present in 80% of cases of patients with advanced cancer who suffer from persistent pain. The aim of the pain treatment is to achieve the maximum analgesic effect while minimizing side effects. The main analgesic agent – morphine is...
Main Authors: | Błaszczyk, Feliks, Droń, Aleksandra |
---|---|
Format: | Online |
Language: | English |
Published: |
Termedia Publishing House
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934054/ |
Similar Items
-
Cancer pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: results from a non-interventional study
by: Nolte, Thomas, et al.
Published: (2013) -
Intractable restless legs syndrome: role of prolonged-release oxycodone–naloxone
by: de Biase, Stefano, et al.
Published: (2016) -
Combined Administration of Oxycodone/Naloxone in Chronic Osteo-Articular Diseases Pain Therapy
by: Rosa, Palomba, et al.
Published: (2014) -
Methodological Issues on a Clinical Trial to Test Tapentadol Prolonged release vs. Oxycodone/Naloxone Prolonged release
by: Bacallao, Jorge, et al.
Published: (2016) -
Developments in managing severe chronic pain: role of oxycodone–naloxone extended release
by: Fanelli, Guido, et al.
Published: (2015)